Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Fremont, CA
SEC filing record 1 source field available
Fiscal year end
31 December
ABVC BIOPHARMA, INC. has filed 781 SEC EDGAR filings since 28 Jun 2002

SEC filing history

Showing 1-25 of 570 matching filings.

Per page
25
Current page
1
8-K File 001-40700

CURRENT REPORT

Filing date
02 Jul 2026
Reporting date
02 Jul 2026
Next action
Verify source filing
10-Q File 001-40700

QUARTERLY REPORT

Filing date
18 May 2026
Reporting date
31 Mar 2026
Next action
Verify source filing
NT 10-Q File 001-40700

NOTIFICATION OF LATE FILING

Filing date
15 May 2026
Reporting date
31 Mar 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
POS AM File 333-255112

POST-EFFECTIVE AMENDMENT NO. 5 TO FORM S-1

Filing date
27 Mar 2026
Reporting date
Not listed
Next action
Verify source filing
8-K File 001-40700

CURRENT REPORT

Filing date
27 Mar 2026
Reporting date
27 Mar 2026
Next action
Verify source filing
DEF 14A File 001-40700

DEFINITIVE PROXY STATEMENT

Filing date
05 Mar 2026
Reporting date
26 Mar 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
10-K File 001-40700

ANNUAL REPORT

Filing date
03 Mar 2026
Reporting date
31 Dec 2025
Next action
Verify source filing
10-Q/A File 001-40700

AMENDMENT NO. 1 TO FORM 10-Q

Filing date
03 Mar 2026
Reporting date
30 Sep 2025
Next action
Verify source filing
8-K File 001-40700

CURRENT REPORT

Filing date
03 Mar 2026
Reporting date
03 Mar 2026
Next action
Verify source filing
PRE 14A File 001-40700

PRELIMINARY PROXY STATEMENT

Filing date
05 Feb 2026
Reporting date
05 Feb 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K/A File 001-40700

AMENDMENT NO. 1 TO FORM 8-K

Filing date
16 Jan 2026
Reporting date
30 Apr 2025
Next action
Verify source filing
424B4 File 333-280411

PROSPECTUS SUPPLEMENT

Filing date
14 Nov 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B4 File 333-271416

PROSPECTUS SUPPLEMENT

Filing date
14 Nov 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B4 File 333-255112

PROSPECTUS SUPPLEMENT

Filing date
14 Nov 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B4 File 333-250899

PROSPECTUS SUPPLEMENT

Filing date
14 Nov 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-40700

CURRENT REPORT

Filing date
03 Nov 2025
Reporting date
03 Nov 2025
Next action
Verify source filing
10-Q File 001-40700

QUARTERLY REPORT

Filing date
03 Nov 2025
Reporting date
30 Sep 2025
Next action
Verify source filing
8-K File 001-40700

CURRENT REPORT

Filing date
30 Oct 2025
Reporting date
28 Oct 2025
Next action
Verify source filing
8-K/A File 001-40700

AMENDMENT NO. 1 TO FORM 8-K

Filing date
12 Sep 2025
Reporting date
18 Oct 2024
Next action
Verify source filing
424B4 File 333-280411

PROSPECTUS SUPPLEMENT

Filing date
15 Aug 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B4 File 333-271416

PROSPECTUS SUPPLEMENT

Filing date
15 Aug 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B4 File 333-276500

PROSPECTUS SUPPLEMENT

Filing date
15 Aug 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B4 File 333-255112

PROSPECTUS SUPPLEMENT

Filing date
15 Aug 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B4 File 333-250899

PROSPECTUS SUPPLEMENT

Filing date
15 Aug 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-40700

CURRENT REPORT

Filing date
14 Aug 2025
Reporting date
14 Aug 2025
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .